Charnick SB - Search Results

1

Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Charnick SB, Kawai R, Nedelman JR, Lemaire M, Niederberger W, Sato H. Charnick SB, et al. J Pharmacokinet Biopharm. 1995 Apr;23(2):217-29. doi: 10.1007/BF02354273. J Pharmacokinet Biopharm. 1995. PMID: 8719238 Review.

2

Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasis.

Elder CA, Moore M, Chang CT, Jin J, Charnick S, Nedelman J, Cohen A, Guzzo C, Lowe N, Simpson K, et al. Elder CA, et al. J Clin Pharmacol. 1995 Sep;35(9):865-75. doi: 10.1002/j.1552-4604.1995.tb04131.x. J Clin Pharmacol. 1995. PMID: 8786246 Clinical Trial.

3

Description of blood pressure changes in patients beginning cyclosporin A therapy.

Charnick SB, Nedelman JR, Chang CT, Hwang DS, Jin J, Moore MA, Wong R, Meligeni J. Charnick SB, et al. Ther Drug Monit. 1997 Feb;19(1):17-24. doi: 10.1097/00007691-199702000-00003. Ther Drug Monit. 1997. PMID: 9029741 Clinical Trial.

4

Pharmacokinetics of SDZ 64-412, a novel antiasthmatic agent, following intravenous, oral, and inhalation dosing in the rat.

Charnick SB, Yu Z, Athill LV, Karara AH, Tse FL, Lau DT. Charnick SB, et al. Biopharm Drug Dispos. 1994 May;15(4):317-27. doi: 10.1002/bdd.2510150406. Biopharm Drug Dispos. 1994. PMID: 8068869

5

Relative bioavailability of Neoral versus Sandimmune in the presence of a P450IIIA and P-glycoprotein inhibitor.

Choc MG, Mueller EA, Robinson WT, Kumle A, Smith HT, Charnick SB. Choc MG, et al. Among authors: charnick sb. Transplant Proc. 1998 Aug;30(5):1664-5. doi: 10.1016/s0041-1345(98)00383-2. Transplant Proc. 1998. PMID: 9723234 Clinical Trial. No abstract available.

6

Validation of a limited sampling model to determine etoposide area under the curve.

Lum BL, Lane KJ, Synold TW, Goram A, Charnick SB, Sikic BI. Lum BL, et al. Among authors: charnick sb. Pharmacotherapy. 1997 Sep-Oct;17(5):887-90. Pharmacotherapy. 1997. PMID: 9324178 Clinical Trial.

7

Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein.

Watanabe T, Kokubu N, Charnick SB, Naito M, Tsuruo T, Cohen D. Watanabe T, et al. Among authors: charnick sb. Br J Pharmacol. 1997 Sep;122(2):241-8. doi: 10.1038/sj.bjp.0701377. Br J Pharmacol. 1997. PMID: 9313931 Free PMC article.

8

Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.

Sonneveld P, Marie JP, Huisman C, Vekhoff A, Schoester M, Faussat AM, van Kapel J, Groenewegen A, Charnick S, Zittoun R, Löwenberg B. Sonneveld P, et al. Leukemia. 1996 Nov;10(11):1741-50. Leukemia. 1996. PMID: 8892677 Clinical Trial.

9

The hydration of proteins in nearly anhydrous organic solvent suspensions.

McMinn JH, Sowa MJ, Charnick SB, Paulaitis ME. McMinn JH, et al. Among authors: charnick sb. Biopolymers. 1993 Aug;33(8):1213-24. doi: 10.1002/bip.360330808. Biopolymers. 1993. PMID: 8364156

10

Computer simulations of cell-target encounter including biased cell motion toward targets: single and multiple cell-target simulations in two dimensions.

Charnick SB, Fisher ES, Lauffenburger DA. Charnick SB, et al. Bull Math Biol. 1991;53(4):591-621. doi: 10.1007/BF02458631. Bull Math Biol. 1991. PMID: 1933031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters